Pfizer was founded in 1894 by Charles Pfizer and Charles Erhart. By the 1950s, Pfizer was established in Belgium, Brazil, Canada, Cuba, Iran, Mexico, Panama, Puerto Rico, Turkey, and the United Kingdom. The company is headquartered in New York. The stock is listed in NYSE, LSE, Euronext, and Swiss exchanges. During the 1980s and 1990s, Pfizer underwent a period of growth sustained by the discovery and marketing of Zoloft, Lipitor, Norvasc, Zithromax, Aricept, Diflucan, and Viagra. Pfizer has recently grown by mergers, including those with WarnerLambert (2000), with Pharmacia (2003), and with Wyeth (2009). Pfizer had the greatest number of blockbuster products in 2009 with 14, which includes 5 inherited through the acquisition of Wyeth. The majority of Pfizer revenues come from the manufacture and sale of biopharmaceutical products. In 2015, Pfizer entered into a definitive agreement to acquire Hospira Inc., the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 per share in cash, for a total enterprise value of approximately $17 billion.
Revenues in 2014 were $49.6 billion, which represented a decrease of 4% compared to 2013. The Research & Development (R&D) expenses went up by $1.7 billion. The income from continuing operations in 2014 was $9.1 billion, compared to $11.4 billion in 2013.
Beta is estimated by regressing the weekly returns of Pfizer on market index DJIA returns during the 5-year period 20102014.
Beta = 0.45
Average return on market index based on 5-year period=11.68%
Risk-free rate is based on the average monthly yield of 10-year treasury bond rate during the period 20122014.
Risk-free rate = 2.18%
Risk premium = 11.68 – 2.18 = 9.5%
Cost of equity = 2.18+0.45*9.5 = 6.46%
The cost of debt is assumed as the yield to maturity on a long-term bond of Pfizer maturing in the year 2038. The yield to maturity is estimated as 5.19%.
Corporate tax rate = 35%
After-tax cost of debt = 5.19 * (1-0.35) = 3.37%
The weights used for estimation of cost of capital are the market value weights of equity and book value weight of debt.
Market value of equity in 2014 = 200,107.6 million
Book value of debt in 2014 = 36,682 million
Total value = 236,789.6 million
The growth rate estimated from both historical and fundamental is approximately 3%. Two-stage growth scenario is assumed in which the net income will grow by 3% in the first stage for 5 years and then by the growth rate of the economy in the stable stage period.
Growth rate in stable period = 2.15%
Growth rate = Reinvestment rate *ROE of pharma industry sector
ROE of pharma industry = 16.4%
Reinvestment rate = 2.15/16.4 = 13%
The reinvestment rate in the stable period is estimated as 13%.
No additional information concerning repayment of old debt and new debt issuance has been provided.
Allergan plans to acquire Pfizer Value. To help Allergan defining an offer price, assess Pfizer intrinsic value through FCFE methodology assuming a two-stage growth scenario.Get Finance homework help today
We aim at 100% customer satisfaction. As such, we never compromise on the quality of our assignment services and strive to maintain the highest standards of work for all our clients. Our writers craft each paper carefully to match the requirements on the instructions form while at the same time being surgical and objective while handling client work.
We receive many applications from writers around the world daily. Nevertheless, we only choose the cream of the crop to tackle your “help with homework” requests. Hence, our homework helpers are highly-qualified individuals who adhere to our quality policy.
We maintain a fair pricing policy for all our homework help services. Our pricing system generates quotations based on the requirements of each paper. Hence regardless of the complexity or duration of a paper, our system determines the most accurate and pocket-friendly price for all our clients.
At MyHomeworkWriters, we guarantee all students swift delivery of their assignments. We understand that time is an essential factor in the academic world. We, therefore, ensure that all assignments are delivered on or before the agreed deadline. This leaves room for editing to incase the client wants changes done to the work delivered by our writers.
We maintain a zero-plagiarism policy in all our papers. Our writers stick to the instructions to deliver plagiarism-free work. Other than that, they extensively research the work they are handling and are keen to avoid any chance of similarities with previously written papers. Our editors check every completed work to ascertain it’s at the set standards.
Our main objective is to assist you through every step of your academic journey. Thus, we completely understand that you might run into trouble once in a while when interacting with our system. If you do run into trouble, please get in touch with our support agents and they will immediately provide you with assistance. Feel free to contact us via the Chat window or email us.
Follow these simple steps to get your homework done
Fill in the order form and provide all details of your assignment.
Choose the payment system that suits you most.
You will be able to track the progress of your paper from our system.
Once your paper is ready, we will email it to you.
Myhomeworkwriters holds a reputation for providing high-quality assignment writing services. You only need to give us all the requirements for your “do my homework” order, and our writers will give you the best results.
Our team is skilled and equipped in searching for information required to complete work handed over to them. Regardless of the complexity of the work, we are determined to get the job done. Extensive research when handling client requests makes it possible for us to be able to stick to the boundaries and guidelines set by the clients. Thus enabling us to keep the work original and plagiarism free.
We have highly qualified writers to assist you whenever you place in "help with my homework" order. Our essay writing service is designed to not only help students get good grades but also excel in their studies. Our writers are highly experienced and educated specialists and professionals who want to do more than creating a difference in the academic field.
Our editors have a keen eye when going through work. They can capture even the smallest of errors. This has been made possible by the fact that we have been in the academic field for more than 5 years now. Thus, they bring with them previous experience when going through work to be able to capture everything. These unique skills make it possible for us to deliver error-free work to our clients.
Our team has very experienced specialists and professionals. This gives us a competitive edge over our competitors. Whenever we receive work that needs to be redone, everyone gets involved. That’s inclusive of our editors. This collective involvement in doing work makes it possible for us to deliver high-quality work to all our clients. Other than that it makes it possible for us to adhere to our originality and plagiarism-free policies.